A phase 1 pilot trial suggests that a novel egg-shell derived peptide may reduce Alzheimer’s biomarkers and improve …
A phase 1 pilot trial suggests that a novel egg-shell derived peptide may reduce Alzheimer’s biomarkers and improve …
New Zealand’s women beat newly-crowned world sevens series champions Australia 21-14 in the final leg in Toulouse.
One company faces regulatory setback while another achieves a Phase III victory, highlighting both urgency and uncertainty in …
Regulatory setback for one biotech contrasts with a major success in sleep disorder treatment, underscoring the high stakes …
A new collaboration aims to develop VMX-C001 to treat severe bleeding in patients on anticoagulants, targeting a 2029 …
Early results from a multi-centre trial indicate that BI-8721 may slow cognitive decline and reduce amyloid biomarkers in …
Interim data in osteogenesis imperfecta show safety remains acceptable, but efficacy thresholds for early stopping were not met
Major change in NIH policy mandates inclusion of organoids, computational models, or other non-animal methods in proposals, likely …
ViiV Healthcare shows long-acting regimens may improve convenience, adherence, and satisfaction for people living with HIV
First 16-week data from the APEX Part A trial reveal APG777 could raise the bar for biologics in …
